Literature DB >> 317021

Immunization during a cerebrospinal meningitis epidemic in the Mongolian People's Republic, 1974-75.

G Jamba, B Bytchenko, G Causse, B Cvjetanović, G Ocirvan, N Tsend, J Kupul, S Tseren, A Batsuri, A Hisigdorj, V Burian.   

Abstract

An epidemic of cerebrospinal meningitis (CSM) in the Mongolian People's Republic, starting in 1969, reached its peak in 1974. In that year and in early 1975, 65 000 children in the 0-8-years age group in the main towns and in the provinces were immunized with meningococcal vaccine of serogroup A. The morbidity rates due to CSM were 12 times higher in the non-immunized than in the immunized children. This result demonstrates the value of an immunization programme to control epidemics of CSM.

Entities:  

Mesh:

Year:  1979        PMID: 317021      PMCID: PMC2395848     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.

Authors:  M H Wahdan; S A Sallam; M N Hassan; A Abdel Gawad; A S Rakha; J E Sippel; R Hablas; W R Sanborn; N M Kassem; S M Riad; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

  1 in total
  7 in total

1.  Epidemiology of meningococcal meningitis in Sahel and Mongolia.

Authors:  R Skalova
Journal:  Infection       Date:  1984       Impact factor: 3.553

Review 2.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

3.  Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.

Authors:  Hani Jokhdar; Ray Borrow; Abdulrazaq Sultan; Mousaed Adi; Christine Riley; Emily Fuller; David Baxter
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Meningococcal disease in Scandinavia.

Authors:  H Peltola; K Jónsdóttir; A Lystad; C J Sievers; I Kallings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

5.  Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

Authors:  F Ambrosch; G Wiedermann; P Crooy; A M George
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

Review 6.  Functional epidemiology of bacterial meningitis.

Authors:  P H Mäkelä
Journal:  Infection       Date:  1984       Impact factor: 3.553

Review 7.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.